Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 5/2016

Open Access 01-05-2016 | Original Article

Feasibility of an eHealth application “OncoKompas” to improve personalized survivorship cancer care

Authors: S. Duman-Lubberding, C.F. van Uden-Kraan, F. Jansen, B.I. Witte, L.A. van der Velden, M. Lacko, P. Cuijpers, C.R. Leemans, I.M. Verdonck-de Leeuw

Published in: Supportive Care in Cancer | Issue 5/2016

Login to get access

Abstract

Purpose

The purpose of this study was to investigate the feasibility of an online self-management application (OncoKompas) among cancer survivors. In OncoKompas, cancer survivors can monitor their quality of life (QOL) via participant reported outcomes (PROs) (“Measure”), which is followed by automatically generated individually tailored feedback (“Learn”) and personalized advice on supportive care services (“Act”).

Methods

A pretest–posttest design was used, conducting a survey before providing access to OncoKompas, and 2 weeks after, followed by an interview by a nurse. Adoption was defined as the percentage of cancer survivors that agreed to participate in the study and returned the T0 questionnaire. Implementation was defined as the percentage of participants that actually used OncoKompas as intended (T1). General satisfaction was assessed based on the mean score of three study-specific questions: (1) general impression of OncoKompas, (2) the user-friendliness, and (3) the ability to use OncoKompas without assistance (10-point Likert scales). Furthermore, satisfaction was measured with the Net Promotor Scale (NPS).

Results

OncoKompas was feasible with an adoption grade of 64 %, an implementation grade of 75–91 %, a mean satisfaction score of 7.3, and a positive NPS (1.9). Sociodemographic and clinical factors and QOL were not associated with satisfaction. Several facilitators and barriers related to the feasibility of OncoKompas were identified.

Conclusion

OncoKompas is considered feasible, but has to be further improved. In order to enhance feasibility and increase satisfaction, we have to balance the time it takes to use OncoKompas, measurement precision, and tailoring towards personalized advices.
Appendix
Available only for authorised users
Literature
1.
A. de Graeff, J. R. de Leeuw, W. J. Ros, G. J. Hordijk, G. H. Blijham, and J. A. Winnubst, “Long-term quality of life of patients with head and neck cancer.,” Laryngoscope, vol. 110, no. 1, pp. 98–106, Jan. 2000.
2.
I. M. Verdonck-de Leeuw, S. E. Eerenstein, M. H. Van der Linden, D. J. Kuik, R. de Bree, and C. R. Leemans, “Distress in spouses and patients after treatment for head and neck cancer.,” Laryngoscope, vol. 117, no. 2, pp. 238–241, Feb. 2007.
3.
N. K. Aaronson, V. Mattioli, O. Minton, J. Weis, C. Johansen, S. O. Dalton, I. M. Verdonck-de Leeuw, K. D. Stein, C. M. Alfano, A. Mehnert, A. de Boer, and L. V. van de Poll-Franse, “Beyond treatment – psychosocial and behavioural issues in cancer survivorship research and practice,” Eur J Cancer Suppl, vol. 12, no. 1, pp. 54–64, Jun. 2014.
4.
E. C. Moser and F. Meunier, “Cancer survivorship: a positive side-effect of more successful cancer treatment,” Eur J Cancer Suppl, vol. 12, no. 1, pp. 1–4, Jun. 2014.
5.
F. Jansen, C. F. van Uden-Kraan, V. van Zwieten, B. I. Witte, and I. M. Verdonck-de Leeuw, “Cancer survivors’ perceived need for supportive care and their attitude towards self-management and eHealth.,” Support Care Cancer, vol. 23, no. 6, pp. 1679–1688, Jun. 2015.
6.
R. McCorkle, E. Ercolano, M. Lazenby, D. Schulman-Green, L. S. Schilling, K. Lorig, and E. H. Wagner, “Self-management: enabling and empowering patients living with cancer as a chronic illness.,” CA Cancer J Clin, vol. 61, no. 1, pp. 50–62, Jan. 2011.
7.
A. J. Mitchell, “Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis.,” J Natl Compr Cancer Netw, vol. 8, no. 4, pp. 487–494, Apr. 2010.
8.
A. J. Mitchell, “Screening for cancer-related distress: when is implementation successful and when is it unsuccessful?,” Acta Oncol, vol. 52, no. 2, pp. 216–224, Feb. 2013.
9.
M. I. Fitch, “Supportive care framework.,” Can Oncol Nurs J, vol. 18, no. 1, pp. 6–24, Jan. 2008.
10.
J. E. W. C. van Gemert-Pijnen, N. Nijland, M. van Limburg, H. C. Ossebaard, S. M. Kelders, G. Eysenbach, and E. R. Seydel, “A holistic framework to improve the uptake and impact of eHealth technologies.,” J. Med. Internet Res., vol. 13, no. 4, p. e111, Jan. 2011.
11.
J. N. Stinson, G. C. Petroz, B. J. Stevens, B. M. Feldman, D. Streiner, P. J. McGrath, and N. Gill, “Working out the kinks: testing the feasibility of an electronic pain diary for adolescents with arthritis.,” Pain Res. Manag., vol. 13, no. 5, pp. 375–382, Jan..
12.
R. van der Vaart, C. H. C. Drossaert, E. Taal, and M. A. F. J. van de Laar, “Patient preferences for a hospital-based rheumatology interactive health communication application and factors associated with these preferences.,” Rheumatology (Oxford)., vol. 50, no. 9, pp. 1618–1626, Sep. 2011.
13.
S. Lubberding, C. F. van Uden-Kraan, E. A. Te Velde, P. Cuijpers, C. R. Leemans, and I. M. Verdonck-de Leeuw, “Improving access to supportive cancer care through an eHealth application: a qualitative needs assessment among cancer survivors.,” J. Clin. Nurs., Feb. 2015.
14.
R. de Bree, I. M. Verdonck-de Leeuw, A. L. Keizer, A. Houffelaar, and C. R. Leemans, “Touch screen computer-assisted health-related quality of life and distress data collection in head and neck cancer patients.,” Clin Otolaryngol, vol. 33, no. 2, pp. 138–142, Apr. 2008.
15.
S. Vosbergen, E. K. Laan, E. B. Colkesen, M. A. J. Niessen, R. A. Kraaijenhagen, M.-L. Essink-Bot, and N. Peek, “Evaluation of end-user satisfaction among employees participating in a web-based health risk assessment with tailored feedback.,” J. Med. Internet Res., vol. 14, no. 5, p. e140, Jan. 2012.
16.
S. M. Kelders, W. T. M. Pots, M. J. Oskam, E. T. Bohlmeijer, and J. E. W. C. van Gemert-Pijnen, “Development of a web-based intervention for the indicated prevention of depression.,” BMC Med Inform Decis Mak, vol. 13, p. 26, Jan. 2013.
17.
R. G. Booth, “Examining the functionality of the DeLone and McLean information system success model as a framework for synthesis in nursing information and communication technology research.,” Comput. Inform. Nurs., vol. 30, no. 6, pp. 330–345, Jun. 2012.
18.
S. Lubberding, C.F. Van Uden-Kraan, W.J.M.J. Cuijpers, C.R. Leemans, and I.M. Verdonck-de Leeuw, “Developing an eHealth portal targeting survivorship cancer care: a user-centred design approach.,” Psycho-Oncology, vol. 22, pp. 15–16, 2013.
19.
Reichheld F, Markey R (2011) the ultimate question 2.0 (revised and expanded edition): how net promoter companies thrive in a customer-driven world. Harvard Business School Press:224
20.
J. F. Piccirillo, R. M. Tierney, I. Costas, L. Grove, and E. L. Spitznagel, “Prognostic importance of comorbidity in a hospital-based cancer registry.,” Jama, vol. 291, no. 20, pp. 2441–2447, May 2004.
21.
N. K. Aaronson, S. Ahmedzai, B. Bergman, M. Bullinger, A. Cull, N. J. Duez, A. Filiberti, H. Flechtner, S. B. Fleishman, and J. C. de Haes, “The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.,” J Natl Cancer Inst, vol. 85, no. 5, pp. 365–376, Mar. 1993.
22.
I. C. Cnossen, C. F. van Uden-Kraan, R. N. P. M. Rinkel, I. J. Aalders, C. J. T. de Goede, R. de Bree, P. Doornaert, D. H. F. Rietveld, J. A. Langendijk, B. I. Witte, C. R. Leemans, and I. M. Verdonck-de Leeuw, “Multimodal guided self-help exercise program to prevent speech, swallowing, and shoulder problems among head and neck cancer patients: a feasibility study.,” J. Med. Internet Res., vol. 16, no. 3, p. e74, Jan. 2014.
23.
C. M. Ruland, T. Andersen, A. Jeneson, S. Moore, G. H. Grimsbø, E. Børøsund, and M. C. Ellison, “Effects of an internet support system to assist cancer patients in reducing symptom distress: a randomized controlled trial.,” Cancer Nurs, vol. 36, no. 1, pp. 6–17, Jan. 2013.
24.
C. M. Ruland, R. M. Maffei, E. Børøsund, A. Krahn, T. Andersen, and G. H. Grimsbø, “Evaluation of different features of an eHealth application for personalized illness management support: cancer patients’ use and appraisal of usefulness.,” Int J Med Inform, vol. 82, no. 7, pp. 593–603, Jul. 2013.
25.
C. K. L. Or and B.-T. Karsh, 2009 “A systematic review of patient acceptance of consumer health information technology.,” J Am Med Inform Assoc, vol. 16, no. 4, pp. 550–560, Jan..
26.
Y. K. Bartlett, D. L. Selby, A. Newsham, A. Keding, D. Forman, J. Brown, G. Velikova, and P. Wright, “Developing a useful, user-friendly website for cancer patient follow-up: users’ perspectives on ease of access and usefulness.,” Eur J Cancer Care (Engl)., vol. 21, no. 6, pp. 747–757, Nov. 2012.
27.
E. Børøsund, M. Cvancarova, M. Ekstedt, S. M. Moore, and C. M. Ruland, “How user characteristics affect use patterns in web-based illness management support for patients with breast and prostate cancer.,” J. Med. Internet Res., vol. 15, no. 3, p. e34, Jan. 2013.
28.
A.-M. Wiggers, N. Peek, R. Kraaijenhagen, and M. Jaspers, “Determinants of eligibility and use of ehealth for cardiac rehabilitation patients: preliminary results.,” Stud Health Technol Inform, vol. 205, pp. 818–822, Jan. 2014.
29.
C. F. Van Uden-Kraan, C. H. C. Drossaert, E. Taal, W. M. Smit, H. J. Bernelot Moens, and M. A. F. J. Van de Laar, “Determinants of engagement in face-to-face and online patient support groups.,” J. Med. Internet Res., vol. 13, no. 4, p. e106, Jan. 2011.
30.
S. M. Kelders, J. E. W. C. Van Gemert-Pijnen, A. Werkman, N. Nijland, and E. R. Seydel, “Effectiveness of a Web-based intervention aimed at healthy dietary and physical activity behavior: a randomized controlled trial about users and usage.,” J. Med. Internet Res., vol. 13, no. 2, p. e32, Jan. 2011.
31.
M. W. Verheijden, M. P. Jans, V. H. Hildebrandt, and M. Hopman-Rock, “Rates and determinants of repeated participation in a web-based behavior change program for healthy body weight and healthy lifestyle.,” J. Med. Internet Res., vol. 9, no. 1, p. e1, Jan. 2007.
32.
Y. M. Chae, H. J. Park, J. G. Cho, G. D. Hong, and K. A. Cheon, “The reliability and acceptability of telemedicine for patients with schizophrenia in Korea.,” J Telemed Telecare, vol. 6, no. 2, pp. 83–90, Jan. 2000.
33.
J.-G. Jeannot, F. Froehlich, V. Wietlisbach, B. Burnand, O. Terraz, and J.-P. Vader, “Patient use of the internet for health care information in Switzerland.,” Swiss Med Wkly, vol. 134, no. 21–22, pp. 307–312, May 2004.
34.
Millard RW, Fintak PA (2002) Use of the internet by patients with chronic illness. Dis Manag Heal Outcomes 10(3):187–194CrossRef
35.
Venkatesh FD, Morris V, Davis MG (2003) User acceptance of information technology: toward a unified view. MIS Quarterly. 27:425–478
36.
V. Voncken-Brewster, H. Tange, A. Moser, Z. Nagykaldi, H. de Vries, and T. van der Weijden, “Integrating a tailored e-health self-management application for chronic obstructive pulmonary disease patients into primary care: a pilot study.,” BMC Fam Pract, vol. 15, p. 4, Jan. 2014.
37.
W. Brouwer, A. Oenema, R. Crutzen, J. de Nooijer, N. K. de Vries, and J. Brug, “What makes people decide to visit and use an internet-delivered behavior-change intervention?,” Health Educ, vol. 109, no. 6, pp. 460–473, Oct. 2009.
38.
J. O. Prochaska, “Multiple health behavior research represents the future of preventive medicine.,” Prev Med (Baltim)., vol. 46, no. 3, pp. 281–285, Mar. 2008.
39.
J. R. Schubart, H. L. Stuckey, A. Ganeshamoorthy, and C. N. Sciamanna, “Chronic health conditions and internet behavioral interventions: a review of factors to enhance user engagement.,” Comput Inform Nurs, vol. 29, no. 2 Suppl, pp. TC9–T20, Feb. 2011.
40.
W. Brouwer, W. Kroeze, R. Crutzen, J. de Nooijer, N. K. de Vries, J. Brug, and A. Oenema, “Which intervention characteristics are related to more exposure to internet-delivered healthy lifestyle promotion interventions? A systematic review.,” J. Med. Internet Res., vol. 13, no. 1, p. e2, Jan. 2011.
Metadata
Title
Feasibility of an eHealth application “OncoKompas” to improve personalized survivorship cancer care
Authors
S. Duman-Lubberding
C.F. van Uden-Kraan
F. Jansen
B.I. Witte
L.A. van der Velden
M. Lacko
P. Cuijpers
C.R. Leemans
I.M. Verdonck-de Leeuw
Publication date
01-05-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 5/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-3004-2

Other articles of this Issue 5/2016

Supportive Care in Cancer 5/2016 Go to the issue

Review Article

Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis

Original Article

Mother-caregiver expectations for function among survivors of childhood brain tumors

Original Article

A qualitative exploration of fear of cancer recurrence (FCR) amongst Australian and Canadian breast cancer survivors

Original Article

Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer

Letter to the editor

Letter to the editor: no increased febrile neutropenia risk to cancer patients receiving lipegfilgrastim—correction of a systematic review and meta-analysis of randomized controlled trials with G-CSF

Original Article

Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis: an Italian population-based study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits